All ProductsDisplaying Products by Catalog Number (6900 - 6999)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 6900 | NNMTi |
| Nicotinamide N-methyltransferase (NNMT) inhibitor; promotes myoblast differentiation | |
| 6902 | Dapansutrile |
| NLRP3 inflammasome inhibitor; disrupts inflammasome formation | |
| 6903 | DPTIP |
| Potent and selective N-SMase2 inhibitor; brain penetrant | |
| 6904 | Idasanutlin |
| Potent MDM2 inhibitor; inhibits MDM2-p53 interaction | |
| 6905 | Ceritinib |
| Highly potent ALK inhibitor; also potently inhibits IR, IGF1R, STK22D and FLT3 | |
| 6907 | VH 032 amide-PEG2-amine |
| VHL ligand with PEG linker and terminal amine for onward chemistry | |
| 6908 | TR 14035 |
| Potent integrin α4β7 and α4β1 (VLA-4) antagonist; orally bioavailable | |
| 6909 | VH 032 phenol-alkylC4-amine |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | |
| 6910 | VH 032 phenol-alkylC6-amine |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | |
| 6911 | VH 032, phenol |
| Hydroxyl functionalized VHL ligand | |
| 6912 | dTAG-7 |
| First generation Degrader for mutant FKBP12F36V fusion proteins; useful alternative to genetic methods for target validation | |
| 6913 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine |
| Cereblon ligand with alkyl-PEG-alkyl linker and terminal amine for onward chemistry | |
| 6914 | dTAGV-1 |
| Potent and selective degrader of mutant FKBP12F36V fusion proteins | |
| 6915 | dTAGV-1-NEG |
| Negative control for dTAGV-1 (Cat. No. 6914) | |
| 6916 | dTAG-13-NEG |
| Negative control for dTAG-13 (Cat. No. 6605) | |
| 6917 | Thalidomide 4'-ether-alkylC4-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6921 | BSJ-03-123 |
| Selective Cdk6 Degrader (PROTAC®) | |
| 6923 | AMZ 30 |
| Potent, selective and irreversible protein phosphatase methylesterase-1 (PME-1) inhibitor | |
| 6927 | Glucagon (Human, Porcine) |
| Endogenous glucagon receptor agonist | |
| 6928 | VU 6001966 |
| Potent and selective negative allosteric modulator of mGlu2 receptors | |
| 6930 | Amphotericin B |
| Forms monovalent ion channels in lipid bilyers; antifungal | |
| 6931 | AF 64394 |
| Potent and selective GPR3 inverse agonist | |
| 6935 | GSK J5 HCl |
| Inactive isomer of GSK J4 (Cat. No. 4594); cell permeable | |
| 6936 | VZ 185 |
| Potent and selective BRD7/9 Degrader (PROTAC®) | |
| 6937 | BSJ-04-132 |
| Selective Cdk4 Degrader (PROTAC®) | |
| 6938 | BSJ-03-204 |
| Selective Cdk4/6 Degrader (PROTAC® | |
| 6939 | cis-VZ 185 |
| Negative control for VZ 185 (Cat. No. 6936) | |
| 6940 | BTD |
| Selective TRPC5 activator | |
| 6941 | Pyr 10 |
| Selective TRPC3 inhibitor | |
| 6943 | dBRD9-A |
| Potent BRD9 Degrader (PROTAC®) | |
| 6944 | Pomalidomide 4'-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6945 | dBET6 |
| Potent and selective (+)-JQ1 based Degrader (PROTAC®) targeting BET bromodomains, active in vivo | |
| 6946 | Thalidomide 4'-oxyacetamide-alkylC8-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6948 | CRBN-6-5-5-VHL |
| Potent and selective cereblon Degrader (PROTAC®); cell-permeable | |
| 6949 | Thalidomide 4'-oxyacetamide-alkylC2-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6950 | Thalidomide 4'-ether-PEG3-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6951 | Thalidomide 4'-ether-PEG5-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6952 | VH 101, phenol |
| Hydroxyl functionalized VHL ligand | |
| 6954 | L-Buthionine sulfoximine |
| Irreversible γ-glutamylcysteine synthetase (γ-GCS) inhibitor; induces ferroptosis | |
| 6955 | Ceapin A7 |
| Selective inhibitor of ATF6α; sensitizes cells to ER stress | |
| 6956 | Galunisertib |
| ALK4 and ALK5 (TGFβRI) inhibitor | |
| 6960 | ABT 199 |
| Selective, high affinity Bcl-2 inhibitor; orally bioavailable | |
| 6961 | FzM1.8 |
| Frizzled 4 allosteric agonist; exhibits biased signaling; preserves stemness | |
| 6962 | JBJ-03-142-02 |
| Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors | |
| 6963 | Pomalidomide 4'-PEG4-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6964 | LY 2119620 |
| Positive allosteric modulator of M2 and M4 receptors | |
| 6965 | CGI 1746 |
| Potent, reversible BTK inhibitor | |
| 6966 | Thalidomide 4'-oxyacetamide-PEG1-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6967 | Thalidomide 4'-oxyacetamide-PEG2-amine |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
| 6968 | Thalidomide 4'-oxyacetamide-alkylC6-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6969 | cis VH 032, amine dihydrochloride |
| Negative control for VH 032, amine (Cat. No. 6462) | |
| 6970 | aTAG 2139 |
| Degrader of MTH1 fusion proteins for use within the aTAG system | |
| 6971 | aTAG 4531 |
| Degrader of MTH1 fusion proteins for use within the aTAG system | |
| 6972 | A 1899 |
| Potent K2P3.1 (TASK-1) and K2P9.1 (TASK-3) blocker | |
| 6973 | NS 3728 |
| VRAC blocker | |
| 6975 | Teniposide |
| DNA topoisomerase II inhibitor; viral transduction enhancer | |
| 6977 | Bobcat339 |
| Ten-eleven translocation methylcytosine dioxygenase (TET) inhibitor | |
| 6978 | AZD 5363 |
| Potent pan-AKT inhibitor | |
| 6979 | SEN 177 |
| Potent glutaminyl cyclase inhibitor; disrupts binding of SIRP-α to CD47 | |
| 6981 | TL 0259 |
| Selective and highly potent Fgr and Lyn kinase inhibitor; orally bioavailable | |
| 6982 | Cyclosporin H |
| Enhances lentiviral transduction | |
| 6984 | KIN001-266 |
| Potent and selective Tpl2 (MAP3K8) inhibitor | |
| 6985 | VH 032 amide-alkylC5-amine |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | |
| 6986 | EG 00229 trifluoroacetate |
| Neuropilin 1 (NRP1) receptor antagonist; inhibits VEGFA binding to NRP1 | |
| 6990 | SET 2 |
| Selective TRPV2 antagonist | |
| 6998 | SHIN 1 |
| Potent SHMT inhibitor |